| 1 |
Zheng J, Zhang J, Cai J, et al. Development of a radiomics model to discriminate ammonium urate stones from uric acid stones in vivo : a remedy for the diagnostic pitfall of dual-energy computed tomography [J]. Chin Med J (Engl), 2024, 137(9): 1095-1104.
|
| 2 |
袁晓亮, 魏汉平, 刘晓武, 等. 泌尿系结石成分构成及其临床特征与肾功能分析 [J]. 中外医学研究, 2022, 20(22): 68-72.
|
| 3 |
Aji K, Maimaijiang M, Song G. Study on changes in urinary relative supersaturation and risk of stone recurrence in patients after urolithiasis surgery [J]. BMC Urol, 2025, 25(1): 258.
|
| 4 |
阮星星, 刘芙香, 周祥福. 欧洲泌尿外科学会尿路结石诊断与治疗指南要点 [J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(6): 758.
|
| 5 |
岑威虎, 沈俊, 夏莎莎, 等. 代谢相关疾病与草酸钙结石形成机制的研究进展 [J]. 中国医学科学院学报, 2025, 47(1): 124-130.
|
| 6 |
Gao J, Xue JF, Xu M, et al. Nanouric acid or nanocalcium phosphate as central nidus to induce calcium oxalate stone formation: a high-resolution transmission electron microscopy study on urinary nanocrystallites [J]. Int J Nanomedicine, 2014, 9: 4399-4409.
|
| 7 |
Origüela V, Lopez-Zaplana A. Gut microbiota: an immersion in dysbiosis, associated pathologies, and probiotics [J]. Microorganisms, 2025, 13(5): 1084.
|
| 8 |
王超, 董旭, 尹新玮, 等. 肠道菌群对草酸钙结石的影响 [J]. 中南大学学报(医学版), 2021, 46(11): 1285-1289.
|
| 9 |
Kim MG, Yang J, Jo SK. Intestinal microbiota and kidney diseases [J]. Kidney Res Clin Pract, 2021, 40(3): 335-343.
|
| 10 |
方道成, 唐春华, 胡媛媛. 肠道菌群对草酸钙肾结石形成的影响 [J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(5): 509-513.
|
| 11 |
刘志楠, 徐卫波, 刘博文, 等. 泌尿系结石与肠道微生态关系研究进展 [J]. 临床泌尿外科杂志, 2022, 37(2): 156-159, 162.
|
| 12 |
Mehta M, Goldfarb DS, Nazzal L. The role of the microbiome in kidney stone formation [J]. Int J Surg, 2016, 36(Pt D): 607-612.
|
| 13 |
何春燕, 张宁南, 杨敏, 等. 肠道与泌尿系统的微生物对肾结石发病机制影响的研究进展 [J]. 微生物学通报, 2022, 49(9): 3967-3978.
|
| 14 |
Li D, Li Z, Liu W. The gut-kidney axis in urolithiasis: roles of gut microbiota, metabolites, and therapeutic implications [J]. Front Microbiol, 2025, 16: 1655808.
|
| 15 |
蒋兆彦, 胡海, 韩天权, 等. 肠道菌群改变与胆固醇结石病 [J]. 外科理论与实践, 2019, 24(2): 93-95.
|
| 16 |
Ticinesi A, Nouvenne A, Chiussi G, et al. Calcium oxalate nephrolithiasis and gut microbiota: not just a gut-kidney axis. A nutritional perspective [J]. Nutrients, 2020, 12(2): 548.
|
| 17 |
Chen X, Zhang F, Cheng L, et al. Dysbiosis of the gut microbiota in calcium oxalate nephrolithiasis is associated with impaired short-chain fatty acid production and systemic metabolomic disruptions [J]. Microbiome, 2025, 14(1): 35.
|
| 18 |
Sadaf H, Raza SI, Hassan SW. Role of gut microbiota against calcium oxalate [J]. Microb Pathog, 2017, 109: 287-291.
|
| 19 |
任向楠, 梁琼麟. 基于质谱分析的代谢组学研究进展 [J]. 分析测试学报, 2017, 36(2): 161-169.
|
| 20 |
Cui T, Yang Y, Lange D, et al. Gut microbiome and metabolome signatures in calcium oxalate stone recurrence: a multi-omics study [J]. Microb Cell Fact, 2026, 25(1): 100.
|
| 21 |
Stanford J, Charlton K, Stefoska-Needham A, et al. The gut microbiota profile of adults with kidney disease and kidney stones: a systematic review of the literature [J]. BMC Nephrol, 2020, 21(1): 215.
|
| 22 |
Yuan T, Xia Y, Li B, et al. Gut microbiota in patients with kidney stones: a systematic review and meta-analysis [J]. BMC Microbiol, 2023, 23(1): 143.
|
| 23 |
Li XM, Amier Y, Wan WL, et al. A novel synbiotic formulation prevents calcium oxalate stones by restoring gut microbiota homeostasis [J]. BMC Microbiol, 2025, 25(1): 673.
|
| 24 |
Ma J, Piao X, Mahfuz S, et al. The interaction among gut microbes, the intestinal barrier and short chain fatty acids [J]. Anim Nutr, 2021, 9: 159-174.
|
| 25 |
Margolis KG, Cryan JF, Mayer EA. The microbiota-gut-brain axis: From motility to mood [J]. Gastroenterology, 2021, 160(5): 1486-1501.
|